Menu
GeneBe

22-21805852-T-G

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate

The NM_002745.5(MAPK1):c.490A>C(p.Lys164Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000082 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MAPK1
NM_002745.5 missense, splice_region

Scores

11
6
1
Splicing: ADA: 0.6378
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.00
Variant links:
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a domain Protein kinase (size 288) in uniprot entity MK01_HUMAN there are 9 pathogenic changes around while only 1 benign (90%) in NM_002745.5
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, MAPK1
PP3
MetaRNN computational evidence supports a deleterious effect, 0.934

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAPK1NM_002745.5 linkuse as main transcriptc.490A>C p.Lys164Gln missense_variant, splice_region_variant 3/9 ENST00000215832.11
MAPK1NM_138957.3 linkuse as main transcriptc.490A>C p.Lys164Gln missense_variant, splice_region_variant 3/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAPK1ENST00000215832.11 linkuse as main transcriptc.490A>C p.Lys164Gln missense_variant, splice_region_variant 3/91 NM_002745.5 P1P28482-1
MAPK1ENST00000398822.7 linkuse as main transcriptc.490A>C p.Lys164Gln missense_variant, splice_region_variant 3/81 P1P28482-1
MAPK1ENST00000544786.1 linkuse as main transcriptc.490A>C p.Lys164Gln missense_variant, splice_region_variant 3/71 P28482-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000824
AC:
119
AN:
1444906
Hom.:
0
Cov.:
30
AF XY:
0.0000668
AC XY:
48
AN XY:
718988
show subpopulations
Gnomad4 AFR exome
AF:
0.0000917
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000397
Gnomad4 EAS exome
AF:
0.0000509
Gnomad4 SAS exome
AF:
0.0000356
Gnomad4 FIN exome
AF:
0.0000944
Gnomad4 NFE exome
AF:
0.0000915
Gnomad4 OTH exome
AF:
0.0000670
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 09, 2023The c.490A>C (p.K164Q) alteration is located in exon 3 (coding exon 3) of the MAPK1 gene. This alteration results from a A to C substitution at nucleotide position 490, causing the lysine (K) at amino acid position 164 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.28
Cadd
Pathogenic
29
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;T;.
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Uncertain
0.091
D
MetaRNN
Pathogenic
0.93
D;D;D
MetaSVM
Uncertain
0.17
D
MutationAssessor
Pathogenic
2.9
M;M;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.94
D
PROVEAN
Uncertain
-3.2
D;D;D
REVEL
Pathogenic
0.77
Sift
Uncertain
0.0010
D;D;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
D;D;.
Vest4
0.88
MutPred
0.85
Loss of ubiquitination at K164 (P = 0.0183);Loss of ubiquitination at K164 (P = 0.0183);Loss of ubiquitination at K164 (P = 0.0183);
MVP
0.97
MPC
2.6
ClinPred
0.99
D
GERP RS
4.8
Varity_R
0.96
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.64
dbscSNV1_RF
Benign
0.68
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr22-22160141; API